Gamida Cell Ltd.

08/10/2022 | Press release | Distributed by Public on 08/10/2022 05:06

Gamida Cell Announces Dosing of First Patient in Company-Sponsored Phase 1/2 Study of NK Cell Therapy Candidate GDA-201